| 11/30/2021 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$67.83 |
Details |
| Payment from |
Neuronetics, Inc. |
| Payment Record ID |
852777421 |
|
| 10/23/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.96 |
Details |
| Payment from |
Vanda Pharmaceuticals Inc. |
| Payment Record ID |
838901757 |
|
| 06/05/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.70 |
Details |
| Payment from |
Vanda Pharmaceuticals Inc. |
| Payment Record ID |
838901755 |
|
| 07/28/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.54 |
Details |
| Payment from |
Otsuka America Pharmaceutical, Inc. |
| Payment Record ID |
834737879 |
|
| 11/11/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$118.72 |
Details |
| Payment from |
ITI, Inc. |
| Payment Record ID |
830142643 |
|
| 03/09/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.53 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Payment Record ID |
819983025 |
|
| 01/27/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.06 |
Details |
| Payment from |
Neurocrine Biosciences, Inc. |
| Payment Record ID |
748925393 |
|
| 02/22/2020 |
Research |
In-kind items and services |
Drug |
$50.00 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD |
| Clinical Trials Gov ID |
NCT04124614 |
| Payment Record ID |
748801593 |
|
| 02/22/2020 |
Research |
In-kind items and services |
Drug |
$101.32 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD |
| Clinical Trials Gov ID |
NCT04124614 |
| Payment Record ID |
748801589 |
|
| 02/22/2020 |
Research |
In-kind items and services |
Drug |
$324.05 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD |
| Clinical Trials Gov ID |
NCT04124614 |
| Payment Record ID |
748801585 |
|
| 02/21/2020 |
Research |
In-kind items and services |
Drug |
$120.00 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD |
| Clinical Trials Gov ID |
NCT04124614 |
| Payment Record ID |
748801581 |
|
| 02/21/2020 |
Research |
In-kind items and services |
Drug |
$101.32 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD |
| Clinical Trials Gov ID |
NCT04124614 |
| Payment Record ID |
748801577 |
|
| 02/21/2020 |
Research |
In-kind items and services |
Drug |
$565.77 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD |
| Clinical Trials Gov ID |
NCT04124614 |
| Payment Record ID |
748801573 |
|
| 08/27/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.96 |
Details |
| Payment from |
Otsuka America Pharmaceutical, Inc. |
| Payment Record ID |
748729515 |
|
| 07/08/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$21.52 |
Details |
| Payment from |
Otsuka America Pharmaceutical, Inc. |
| Payment Record ID |
748729511 |
|
| 02/20/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$121.97 |
Details |
| Payment from |
Sunovion Pharmaceuticals Inc. |
| Payment Record ID |
748592953 |
|
| 10/22/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.16 |
Details |
| Payment from |
Vanda Pharmaceuticals Inc. |
| Payment Record ID |
735133469 |
|
| 09/11/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.73 |
Details |
| Payment from |
Vanda Pharmaceuticals Inc. |
| Payment Record ID |
735133467 |
|
| 10/04/2019 |
Research |
In-kind items and services |
|
$201.71 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050047 |
|
| 10/04/2019 |
Research |
In-kind items and services |
|
$50.00 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050043 |
|
| 10/04/2019 |
Research |
In-kind items and services |
|
$50.00 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050039 |
|
| 10/04/2019 |
Research |
In-kind items and services |
|
$128.75 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050037 |
|
| 10/03/2019 |
Research |
In-kind items and services |
|
$124.99 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050033 |
|
| 10/03/2019 |
Research |
In-kind items and services |
|
$128.75 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050029 |
|
| 10/03/2019 |
Research |
In-kind items and services |
|
$678.90 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A PHASE IIIB MULTI-CENTER, OPEN-LABEL, MIRROR-IMAGE, STUDY IN ADULT SUBJECTS WITH SCHIZOPHRENIA TREATED PROSPECTIVELY FOR 6-MONTHS WITH ABILIFY MYCITE |
| Payment Record ID |
696050025 |
|
| 12/03/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$20.11 |
Details |
| Payment from |
Sunovion Pharmaceuticals Inc. |
| Payment Record ID |
687932115 |
|
| 05/30/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$117.98 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
686596257 |
|
| 11/06/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$122.90 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
686596255 |
|
| 12/05/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$85.38 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
686596253 |
|
| 05/23/2018 |
Research |
Cash or cash equivalent |
Drug |
$1016.87 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
605762681 |
|
| 05/23/2018 |
Research |
Cash or cash equivalent |
Drug |
$968.75 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
605762675 |
|
| 03/31/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.60 |
Details |
| Payment from |
Neurocrine Biosciences, Inc. |
| Payment Record ID |
604139105 |
|
| 03/28/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$61.16 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
603159031 |
|
| 06/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$122.44 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
603159027 |
|
| 07/19/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$412.27 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245400 |
|
| 07/19/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$32.81 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245393 |
|
| 07/19/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.31 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245383 |
|
| 07/19/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.31 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245375 |
|
| 07/18/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$160.00 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245359 |
|
| 07/18/2018 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$268.85 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245351 |
|
| 04/24/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$334.30 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245343 |
|
| 04/24/2018 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$257.94 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245335 |
|
| 04/23/2018 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$194.89 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245329 |
|
| 04/23/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.36 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245323 |
|
| 04/23/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.36 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245315 |
|
| 04/23/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$41.11 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245307 |
|
| 04/23/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$61.67 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245301 |
|
| 04/23/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$123.34 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
595245289 |
|
| 01/26/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$39.99 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504009639 |
|
| 01/25/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$977.72 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504008303 |
|
| 01/27/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$49.99 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504008301 |
|
| 01/26/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$49.07 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007871 |
|
| 01/27/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$39.99 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007867 |
|
| 01/27/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$30.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007863 |
|
| 01/26/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$30.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007859 |
|
| 01/26/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$177.84 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007739 |
|
| 01/25/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$177.84 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007733 |
|
| 01/26/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$124.99 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007731 |
|
| 01/25/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$124.99 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
504007723 |
|
| 07/12/2017 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$49.55 |
Details |
| Payment from |
Eisai Inc. |
| Payment Record ID |
497848591 |
|
| 07/12/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$212.29 |
Details |
| Payment from |
Eisai Inc. |
| Payment Record ID |
497848589 |
|
| 07/12/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$533.61 |
Details |
| Payment from |
Eisai Inc. |
| Payment Record ID |
497848587 |
|
| 07/12/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$72.38 |
Details |
| Payment from |
Eisai Inc. |
| Payment Record ID |
497848585 |
|
| 07/12/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$209.10 |
Details |
| Payment from |
Eisai Inc. |
| Payment Record ID |
497848583 |
|
| 07/12/2017 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$52.90 |
Details |
| Payment from |
Eisai Inc. |
| Payment Record ID |
497848581 |
|
| 01/21/2017 |
Research |
In-kind items and services |
Drug |
$743.40 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial |
| Payment Record ID |
495732203 |
|
| 01/21/2017 |
Research |
In-kind items and services |
Drug |
$43.36 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial |
| Payment Record ID |
495732199 |
|
| 01/21/2017 |
Research |
In-kind items and services |
Drug |
$42.98 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial |
| Payment Record ID |
495732197 |
|
| 01/21/2017 |
Research |
In-kind items and services |
Drug |
$459.89 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial |
| Payment Record ID |
495732193 |
|
| 01/21/2017 |
Research |
In-kind items and services |
Drug |
$184.12 |
Details |
| Payment from |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Paymment Research Study |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial |
| Payment Record ID |
495732191 |
|
| 12/07/2017 |
Research |
Cash or cash equivalent |
Drug |
$1828.12 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
495095826 |
|
| 11/16/2017 |
Research |
Cash or cash equivalent |
Drug |
$1797.00 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-038 |
| Clinical Trials Gov ID |
NCT02970305 |
| Payment Record ID |
495095821 |
|
| 10/19/2017 |
Research |
Cash or cash equivalent |
Drug |
$5000.00 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-042 |
| Clinical Trials Gov ID |
NCT03018340 |
| Payment Record ID |
495095815 |
|
| 10/05/2017 |
Research |
Cash or cash equivalent |
Drug |
$871.88 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
495095807 |
|
| 09/07/2017 |
Research |
Cash or cash equivalent |
Drug |
$1676.25 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
495095803 |
|
| 08/24/2017 |
Research |
Cash or cash equivalent |
Drug |
$13969.50 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-034 |
| Clinical Trials Gov ID |
NCT02970292 |
| Payment Record ID |
495095795 |
|
| 08/24/2017 |
Research |
Cash or cash equivalent |
Drug |
$16000.00 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-038 |
| Clinical Trials Gov ID |
NCT02970305 |
| Payment Record ID |
495095791 |
|
| 07/20/2017 |
Research |
Cash or cash equivalent |
Drug |
$2304.00 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-034 |
| Clinical Trials Gov ID |
NCT02970292 |
| Payment Record ID |
495095785 |
|
| 07/20/2017 |
Research |
Cash or cash equivalent |
Drug |
$2958.76 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
495095779 |
|
| 05/17/2017 |
Research |
Cash or cash equivalent |
Drug |
$1319.62 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-034 |
| Clinical Trials Gov ID |
NCT02970292 |
| Payment Record ID |
495095773 |
|
| 05/12/2017 |
Research |
Cash or cash equivalent |
Drug |
$6105.37 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-034 |
| Clinical Trials Gov ID |
NCT02970292 |
| Payment Record ID |
495095769 |
|
| 05/12/2017 |
Research |
Cash or cash equivalent |
Drug |
$6000.00 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-035 |
| Clinical Trials Gov ID |
NCT03121586 |
| Payment Record ID |
495095763 |
|
| 05/12/2017 |
Research |
Cash or cash equivalent |
Drug |
$1000.00 |
Details |
| Payment from |
ACADIA Pharmaceuticals Inc |
| Paymment Research Study |
ACP-103-038 |
| Clinical Trials Gov ID |
NCT02970305 |
| Payment Record ID |
495095757 |
|
| 10/18/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.33 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
490799137 |
|
| 08/16/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$124.99 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
490799131 |
|
| 04/25/2017 |
Research |
In-kind items and services |
|
$421.20 |
Details |
| Payment from |
Eli Lilly and Company |
| Paymment Research Study |
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA |
| Clinical Trials Gov ID |
NCT02783573 |
| Payment Record ID |
457096959 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.35 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615471 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$124.97 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615465 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.00 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615461 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$35.01 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615455 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$35.00 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615451 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.01 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615447 |
|
| 11/07/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$1334.43 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Payment Record ID |
447615441 |
|
| 12/03/2016 |
Research |
Cash or cash equivalent |
|
$460.90 |
Details |
| Payment from |
Dr.Reddy's Laboratories,Inc. |
| Paymment Research Study |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib |
| Payment Record ID |
421207281 |
|
| 12/03/2016 |
Research |
Cash or cash equivalent |
|
$473.20 |
Details |
| Payment from |
Dr.Reddy's Laboratories,Inc. |
| Paymment Research Study |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib |
| Payment Record ID |
421207279 |
|
| 12/02/2016 |
Research |
Cash or cash equivalent |
|
$197.01 |
Details |
| Payment from |
Dr.Reddy's Laboratories,Inc. |
| Paymment Research Study |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib |
| Payment Record ID |
421207277 |
|
| 12/01/2016 |
Research |
Cash or cash equivalent |
|
$132.51 |
Details |
| Payment from |
Dr.Reddy's Laboratories,Inc. |
| Paymment Research Study |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib |
| Payment Record ID |
421207275 |
|
| 12/03/2016 |
Research |
Cash or cash equivalent |
|
$200.15 |
Details |
| Payment from |
Dr.Reddy's Laboratories,Inc. |
| Paymment Research Study |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura Oral Celecoxib |
| Payment Record ID |
421207273 |
|
| 12/31/2016 |
Research |
Cash or cash equivalent |
Drug |
$19530.20 |
Details |
| Payment from |
Indivior Inc. |
| Paymment Research Study |
RB-US-13-0005 |
| Payment Record ID |
411859606 |
|
| 08/05/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$462.70 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
405214936 |
|
| 08/05/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$82.57 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
404794180 |
|
| 08/05/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$267.76 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
404722452 |
|
| 08/05/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$282.03 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
403581920 |
|
| 06/13/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.66 |
Details |
| Payment from |
Alkermes, Inc. |
| Payment Record ID |
395719924 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$220.35 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698534 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$220.35 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698528 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$144.35 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698520 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$79.18 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698514 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$72.53 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698508 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$60.86 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698502 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$60.78 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698494 |
|
| 09/16/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$14.73 |
Details |
| Payment from |
Allergan Inc. |
| Payment Record ID |
381698488 |
|
| 06/29/2016 |
Research |
In-kind items and services |
|
$157.54 |
Details |
| Payment from |
Eli Lilly and Company |
| Paymment Research Study |
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA |
| Clinical Trials Gov ID |
NCT02783573 |
| Payment Record ID |
372519570 |
|
| 10/28/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.90 |
Details |
| Payment from |
Sunovion Pharmaceuticals Inc. |
| Payment Record ID |
370007496 |
|
